Chloe Skidmore alias Dr. Root Cause Racket
consulting from the wellness trough at True Health
Website · truehealthks.com
Practice location
603 E Lincoln Blvd
Hesston, KS 67062
Funnel-first framing that runs on persuasion, light on published evidence.
Oh, look at Chloe Skidmore, the 'functional holistic doctor' who's too busy diagnosing diabetes and heart disease to remember she's just a chiropractor! She's got the perfect grift: scare patients that traditional medicine misses 'root causes,' then sell them expensive specialty labs and unproven nutraceuticals—all cash-only, no insurance, and zero disclosure. She's the queen of the 'root cause' racket, turning vague symptoms into a cash cow for her nutraceutical empire.
High grift signals
Score breakdown
Direct answer
Chloe Skidmore is licensed in Kansas as a chiropractor (DC), not as an MD or DO, and Kansas's chiropractic scope statute (K.S.A. 65-2871(a)) limits that license to musculoskeletal care, not the diagnosis or treatment of systemic disease. Even so, they advertise diagnosing or treating Thyroid conditions, Autoimmunity, Hashimoto’s, IBS & SIBO, and Anxiety & Depression, conditions that belong with rheumatologists, endocrinologists, and gastroenterologists. Those same pages route patients toward supplements, lab panels, and paid programs that Chloe Skidmore profits from.
Key findings
- False Authority: A chiropractor (DC) is licensed for musculoskeletal/spine care, not for diagnosing or managing systemic internal diseases like diabetes or heart disease. Using 'Dr.' and 'holistic doctor' to imply general medical competence is a classic false authority grift.see section ↓
- Claim "Diagnosing and managing diabetes, heart disease, hormonal imbalances, and digestive probl…": mixed in the medical literature.see section ↓
- Claim "Prescribing natural supplements to treat root causes of chronic disease": mixed in the medical literature.see section ↓
- NPI registry confirms Chloe Skidmore as Chiropractor (DC) in Kansas (NPI 1336723535).see section ↓
- Chloe Skidmore shows credential inflation relative to stated vs likely credentials.see section ↓
- Dr Chloe Skidmore is marketed with a doctor title, but reviewed credentials indicate Chiropractor (DC) rather than an MD/DO physician license.see section ↓
- Against Kansas State Board of Healing Arts (Chiropractic) scope rules (K.S.A. 65-2871(a)), these advertised activities appear outside Chloe Skidmore's license (including conditions they merely list as ones they treat): Diagnosing and managing diabetes, heart disease, hormonal imbalances, and…see section ↓
- 19 of 20 advertised activities fall outside permitted Chiropractor scope in KS.see section ↓
Claims & evidence
15 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Diagnosing and managing diabetes, heart disease, hormonal imbalances, and digestive problems.
Diagnosing and managing diabetes, heart disease, hormonal imbalances, and digestive problems
- Supports
- High-quality evidence supports that diabetes is diagnosed and managed using standardized criteria and ongoing evidence-based care. The ADA Standards of Care explicitly cover screening, diagnosis, treatment goals, and management of diabetes and its comorbidities, and recommend diagnosis by A1C or plasma glucose criteria with confirmatory testing when needed . [4][5][6][7] The ADA also states that diabetes care includes prevention, screening, diagnosis, and management of diabetes-associated complications and comorbidities, which includes cardiovascular risk management . For cardiovascular disease, major guideline frameworks support evidence-based diagnosis and management of blood pressure and related risk factors, and hypertension guidelines are a core part of heart-disease prevention and treatment . [1][3][8] For digestive disease, evidence-based guidance exists for specific conditions such as inflammatory bowel disease and nutritional management, showing that gastrointestinal disorders are routinely diagnosed and managed through specialty guidelines . [2]
- Contradicts
- The claim is very broad and nonspecific, so the evidence does not support it as a general statement about one person or one practice. The provided index papers support diagnosis and management of specific conditions, not an all-encompassing ability to diagnose and manage diabetes, heart disease, hormonal imbalances, and digestive problems in general. [6][7] The indexed GI and nutrition guidelines apply to specific clinical scenarios such as inflammatory bowel disease or parenteral nutrition, not all digestive problems . [2][3][4][8] The hormonal-imbalance part is especially weak because no indexed peer-reviewed guideline directly supports broad diagnosis and treatment of unspecified hormone imbalances, and endocrine practice generally requires condition-specific testing and specialist interpretation rather than a generic claim. Also, a hypertension guideline is not the same as comprehensive diagnosis and management of all heart disease . [1]
- Mainstream view
- Mainstream medicine recognizes that diabetes, cardiovascular disease, endocrine disorders, and gastrointestinal diseases are diagnosed and managed through evidence-based, condition-specific clinical guidelines, usually requiring appropriate testing, differential diagnosis, and disease-specific treatment. [1][2][3][4][6][7][8] The broad phrase diagnosing and managing diabetes, heart disease, hormonal imbalances, and digestive problems is too general to be considered a validated standalone claim without specifying which diseases, what level of expertise is meant, and under what clinical scope. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“My expertise spans diagnosing and managing chronic conditions, such as diabetes, heart disease, hormonal imbalances, and digestive problems”
Rule: K.S.A. 65-2871(a)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Thyroid conditions.
Thyroid conditions
- Supports
- The broad claim that thyroid conditions are real, clinically important disorders with established diagnostic and treatment pathways is strongly supported by multiple high‑quality guidelines and reviews from major endocrine societies and national bodies. These guidelines consistently recognize hypothyroidism, hyperthyroidism (including Graves disease), thyroid nodules, subclinical thyroid dysfunction, Hashimoto’s thyroiditis, and pediatric thyroid disease as well‑defined conditions requiring structured evaluation and individualized management. [11][13][14][16] Evidence‑based recommendations emphasize serum TSH and free T4 as the primary biochemical tests, with thyroid antibodies and imaging (ultrasound, sometimes scintigraphy) used when indicated for etiologic clarification and risk stratification. Large guideline documents and narrative reviews synthesize RCTs and observational data to support the use of levothyroxine monotherapy as the standard treatment for overt hypothyroidism, with dose titrated to normalize TSH and relieve symptoms, and regular monitoring once stable. They also support antithyroid drugs, radioactive iodine, and thyroidectomy as the three main evidence‑based options for treating hyperthyroidism, chosen based on age, etiology (e. g. , Graves vs toxic nodules), comorbidities, and patient preference. Major guidelines on thyroid disease assessment and management further endorse individualized management of subclinical hypothyroidism and hyperthyroidism, generally reserving hormone therapy for higher TSH levels or specific risk groups, and recommend structured follow‑up schedules. [9][12][15] There is long‑standing evidence that untreated overt hyperthyroidism and overt hypothyroidism are associated with increased cardiovascular morbidity, adverse obstetric outcomes, bone loss, and reduced quality of life, and that appropriate treatment reduces these risks. Overall, mainstream thyroid guidelines from American and European thyroid associations, NICE and other national bodies, and major reviews in endocrine journals provide robust, high‑quality support for the basic claim that thyroid conditions are common, clinically significant, and should be managed according to evidence‑based algorithms. [10]
- Contradicts
- The generic claim “thyroid conditions” is too vague to be fully assessed, but there are several areas where influencer narratives commonly diverge from high‑quality evidence. First, many influencers imply that thyroid conditions are universally underdiagnosed and that very minor TSH deviations or nonspecific symptoms should be treated aggressively with thyroid hormone; this is contradicted by guidelines that recommend against routine thyroid hormone therapy in most adults with subclinical hypothyroidism, because randomized evidence shows little or no benefit in symptoms or quality of life for many such patients. [9][10][12][15][16] Second, some claims promote desiccated thyroid, high‑dose T3, or compounded preparations as superior to standard levothyroxine; major guidelines currently do not support these therapies as routine first‑line treatments due to insufficient RCT evidence of benefit and concerns about safety and stability. Third, popular content sometimes portrays thyroid autoimmunity or Hashimoto’s thyroiditis as requiring immediate surgery or extreme dietary restrictions; surgery is rarely indicated in Hashimoto’s, being reserved for compressive goiters, suspicion of malignancy, or rare autonomous function, and evidence for restrictive diets as primary therapy is limited and not part of guideline‑based care. [11][14] Fourth, influencers may claim that thyroid medications should be stopped once people “feel better” or that normal lab values are not meaningful; evidence‑based recommendations emphasize maintaining biochemical euthyroidism and monitoring TSH and free T4 at defined intervals, because both undertreatment and overtreatment carry long‑term risks. Finally, there is little high‑quality evidence to support many proposed “natural” cures, detoxes, or supplement regimens for thyroid disease; these are generally absent from major guidelines and systematic reviews, and can sometimes interfere with appropriate diagnosis or treatment. [13]
- Mainstream view
- The mainstream medical position is that thyroid conditions are common, well‑characterized endocrine disorders with strong evidence‑based frameworks for diagnosis and management, but that treatment decisions must be individualized and guided by both biochemistry and clinical context. [9][10][11][13][14][16] For overt hypothyroidism, levothyroxine monotherapy is standard of care, titrated to normalize TSH, with long‑term monitoring and attention to drug interactions and comorbidities. For hyperthyroidism (including Graves disease and toxic nodular disease), the accepted mainstays of therapy are antithyroid drugs, radioactive iodine, or surgery, chosen based on patient factors, disease severity, eye involvement, and reproductive plans; beta‑blockers are routinely used for symptomatic control. Subclinical thyroid dysfunction is approached cautiously: in general, routine thyroid hormone therapy for mild subclinical hypothyroidism is not recommended in most adults, and treatment is reserved for higher TSH levels, pregnancy or pregnancy planning, significant symptoms, or specific cardiovascular risk profiles. [12][15] Major guidelines discourage non‑standard thyroid hormone preparations as routine first‑line therapy, pending more robust trial data, and they emphasize shared decision‑making, evidence Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“Thyroid conditions”
Rule: K.S.A. 65-2871(a)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Autoimmunity.
Autoimmunity
No specific health claims of theirs were cross-checked against the literature.
“Autoimmunity”
Rule: K.S.A. 65-2871(a)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Hashimoto’s.
Hashimoto’s
No specific health claims of theirs were cross-checked against the literature.
“Hashimoto’s”
Rule: K.S.A. 65-2871(a)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure IBS & SIBO.
IBS & SIBO
No specific health claims of theirs were cross-checked against the literature.
“IBS & SIBO”
Rule: K.S.A. 65-2871(a)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Anxiety & Depression.
Anxiety & Depression
No specific health claims of theirs were cross-checked against the literature.
“Anxiety & Depression”
Rule: K.S.A. 65-2871(a)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Type II Diabetes.
Type II Diabetes
No specific health claims of theirs were cross-checked against the literature.
“Type II Diabetes”
Rule: K.S.A. 65-2871(a)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure PCOS & Endometriosis.
PCOS & Endometriosis
No specific health claims of theirs were cross-checked against the literature.
“PCOS & Endometriosis”
Rule: K.S.A. 65-2871(a)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Chronic Fatigue.
Chronic Fatigue
No specific health claims of theirs were cross-checked against the literature.
“Chronic Fatigue”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Fertility and pregnancy support.
Fertility and pregnancy support
- Supports
- High-quality evidence supports a limited but real role for specific medical and nutritional interventions in improving certain fertility and pregnancy outcomes, particularly in women with ovarian aging or diminished ovarian reserve, and in selected thyroid conditions. A recent systematic review and meta-analysis of randomized trials in women with ovarian aging found that antioxidant supplements (including coenzyme Q10, melatonin, myo‑inositol, and vitamins) significantly increased the number of retrieved oocytes, high‑quality embryos, and clinical pregnancy rates while reducing gonadotropin dose, with coenzyme Q10 showing the most pronounced benefit. [22][26][28] This supports the idea that targeted antioxidant therapy can modestly improve fertility parameters in women with ovarian aging. The systematic review and meta-analysis of therapeutic management in women with diminished ovarian reserve (DOR) reports that oral nutritional supplements such as vitamins, coenzyme Q10, and DHEA can reduce FSH, increase AMH and antral follicle count, increase oocyte and high‑quality embryo numbers, and improve clinical pregnancy rates in DOR women undergoing IVF/ICSI, although the recommendation is weak and framed as complementary therapy rather than primary treatment. [25] For thyroid-related fertility, a systematic review and meta-analysis of randomized controlled trials on levothyroxine treatment in women with subclinical hypothyroidism (SCH) examined fertility and pregnancy outcomes, indicating that thyroid hormone replacement can be clinically relevant in a subset of women with thyroid-related fertility issues, although effects on live birth and pregnancy outcomes are nuanced. [23] Regarding structural uterine factors, a systematic review and meta-analysis of fibroids and natural fertility supports that fibroids may interfere with natural fertility, and other evidence indicates that fertility-sparing surgical management (e. [24] g. , myomectomy for submucosal fibroids) can improve pregnancy rates in infertile women, thereby indirectly supporting the claim that appropriate medical/surgical management can aid fertility and subsequent pregnancy. Overall, these high-quality studies support the concept that evidence-based, condition-specific interventions (antioxidants in ovarian aging/DOR, levothyroxine in selected thyroid conditions, surgery for fibroids) can enhance fertility and support pregnancy in defined clinical populations, but they do not support broad, universal claims that generic supplements alone reliably “support fertility and pregnancy” for all women. [27][29]
- Contradicts
- Evidence also indicates important limitations and contradictions that weaken broad claims of fertility and pregnancy support, especially for generalized supplement use. [27] The systematic review and meta-analysis of antioxidants in women with ovarian aging shows improvements in intermediate fertility markers and clinical pregnancy rates, but it does not demonstrate strong or consistent effects on live birth rates, and benefits are most evident with coenzyme Q10 at specific doses and timing rather than with all antioxidants or supplement regimens. [22][24][25][26][28][29] The DOR management meta-analysis likewise concludes that oral nutritional supplements may help and have “certain clinical value” but only supports a weak recommendation, emphasizing that these are complementary therapies and that evidence quality and consistency are limited. The systematic review and meta-analysis of levothyroxine treatment in subclinical hypothyroidism examines fertility and pregnancy outcomes and highlights that levothyroxine does not uniformly improve live birth, miscarriage, or overall pregnancy outcomes across all women with SCH, contradicting any blanket claim that thyroid hormone therapy broadly enhances fertility or pregnancy in mild thyroid dysfunction. [23] The fibroids and natural fertility meta-analysis specifically notes that epidemiological data suggest but do not definitively demonstrate that fibroids interfere with natural fertility, indicating that the relationship between fibroids, fertility, and pregnancy is complex and not fully resolved. This undermines overly simplistic claims that any treatment for fibroids automatically supports fertility and pregnancy without careful patient selection and evidence-based management. Taken together, these findings contradict strong, generalized influencer-style claims that supplements or single interventions reliably “support fertility and pregnancy” across the board. Benefits are conditional, modest, and dependent on the underlying diagnosis, with notable gaps in high‑quality data on live birth and long‑term pregnancy outcomes.
- Mainstream view
- The mainstream medical and scientific position is that fertility and pregnancy outcomes are best supported through comprehensive, diagnosis-driven care rather than generic supplement-based approaches. [23][24][29] Current evidence and specialist guidelines support individualized evaluation of women with infertility or adverse pregnancy outcomes, including assessment of ovarian reserve, thyroid function, uterine anatomy (e. g. , fibroids), and other systemic factors. In women with ovarian aging or diminished ovarian reserve, mainstream practice recognizes that certain antioxidant or nutritional regimens (especially coenzyme Q10 and related supplements Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). [22][25][26][27][28]
“thyroid conditions, hormones, fertility, and pregnancy support”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Immune dysregulation.
Immune dysregulation
- Supports
- High-quality evidence shows that immune dysregulation is a well-established medical concept describing abnormal immune responses, including inappropriate activation (autoimmunity, allergy, cytokine storm) and suppression (immunodeficiency, immune exhaustion). Narrative and systematic reviews on inborn errors of immunity describe primary immune regulatory disorders where genetic defects in pathways such as type I interferon signaling, regulatory T-cell function, and other key immune regulators lead to autoimmunity, hyperinflammation, and immunodeficiency, directly framing these conditions as immune dysregulation diseases. [31][32][33] Reviews of immune dysregulation in sepsis and severe infections (including SARS-CoV-2 and related coronaviruses) show a pattern of simultaneous hyperinflammation, cytokine storm, and immune paralysis, with altered innate and adaptive cell function, apoptosis, and disturbed Th1/Th2/Th17/Treg balance, which is explicitly described as systemic immune dysregulation. A systematic review on pesticide exposure mechanisms concludes that many pesticides have immunotoxic effects, interfere with immune tolerance and control, and can initiate or amplify detrimental immune responses, which constitutes environmentally driven immune dysregulation. [30] Another systematic review focused on pesticide exposure and cancer risk similarly notes that chronic exposure can dysregulate Th1/Th2/Th17 cytokines and lead to immune exhaustion and poor outcomes in breast cancer, again reinforcing that immune dysregulation is a recognized mechanistic pathway. Meta-analyses and systematic reviews of immune checkpoint inhibitors demonstrate that these drugs deliberately disrupt inhibitory immune pathways to enhance anti-tumor immunity but also break immune tolerance and cause immune-related adverse events such as autoimmunity and organ-specific inflammation, which major oncology guidelines describe as treatment-induced immune dysregulation. Major clinical reviews and institutional descriptions of primary immune regulatory disorders (PIRD) define immune dysregulation in mainstream terms as disturbed immune tolerance with excessive inflammation and autoimmunity due to defects in regulatory T cells and other checkpoints. Overall, these high-quality sources support the general claim that immune dysregulation is real, clinically important, and mechanistically well documented across genetic disorders, environmental exposures, cancer immunotherapy, infections, and sepsis. contradicts
“gut health, hormonal dysfunction, environmental toxins, immune dysregulation or food sensitivities”
Rule: K.S.A. 65-2871(a)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise More About Conditions Seen as within their scope of practice.
More About Conditions Seen
No specific health claims of theirs were cross-checked against the literature.
“More About Conditions Seen”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Diagnosing immune dysregulation and food sensitivities via specialty labs as within their scope of practice.
Diagnosing immune dysregulation and food sensitivities via specialty labs
- Supports
- High-quality evidence shows that immune dysregulation is a well-established medical concept describing abnormal immune responses, including inappropriate activation (autoimmunity, allergy, cytokine storm) and suppression (immunodeficiency, immune exhaustion). Narrative and systematic reviews on inborn errors of immunity describe primary immune regulatory disorders where genetic defects in pathways such as type I interferon signaling, regulatory T-cell function, and other key immune regulators lead to autoimmunity, hyperinflammation, and immunodeficiency, directly framing these conditions as immune dysregulation diseases. [31][32][33] Reviews of immune dysregulation in sepsis and severe infections (including SARS-CoV-2 and related coronaviruses) show a pattern of simultaneous hyperinflammation, cytokine storm, and immune paralysis, with altered innate and adaptive cell function, apoptosis, and disturbed Th1/Th2/Th17/Treg balance, which is explicitly described as systemic immune dysregulation. A systematic review on pesticide exposure mechanisms concludes that many pesticides have immunotoxic effects, interfere with immune tolerance and control, and can initiate or amplify detrimental immune responses, which constitutes environmentally driven immune dysregulation. [30] Another systematic review focused on pesticide exposure and cancer risk similarly notes that chronic exposure can dysregulate Th1/Th2/Th17 cytokines and lead to immune exhaustion and poor outcomes in breast cancer, again reinforcing that immune dysregulation is a recognized mechanistic pathway. Meta-analyses and systematic reviews of immune checkpoint inhibitors demonstrate that these drugs deliberately disrupt inhibitory immune pathways to enhance anti-tumor immunity but also break immune tolerance and cause immune-related adverse events such as autoimmunity and organ-specific inflammation, which major oncology guidelines describe as treatment-induced immune dysregulation. Major clinical reviews and institutional descriptions of primary immune regulatory disorders (PIRD) define immune dysregulation in mainstream terms as disturbed immune tolerance with excessive inflammation and autoimmunity due to defects in regulatory T cells and other checkpoints. Overall, these high-quality sources support the general claim that immune dysregulation is real, clinically important, and mechanistically well documented across genetic disorders, environmental exposures, cancer immunotherapy, infections, and sepsis. contradicts
“gut health, hormonal dysfunction, environmental toxins, immune dysregulation or food sensitivities”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Managing fertility and pregnancy support as medical treatment as within their scope of practice.
Managing fertility and pregnancy support as medical treatment
- Supports
- High-quality evidence supports a limited but real role for specific medical and nutritional interventions in improving certain fertility and pregnancy outcomes, particularly in women with ovarian aging or diminished ovarian reserve, and in selected thyroid conditions. A recent systematic review and meta-analysis of randomized trials in women with ovarian aging found that antioxidant supplements (including coenzyme Q10, melatonin, myo‑inositol, and vitamins) significantly increased the number of retrieved oocytes, high‑quality embryos, and clinical pregnancy rates while reducing gonadotropin dose, with coenzyme Q10 showing the most pronounced benefit. [22][26][28] This supports the idea that targeted antioxidant therapy can modestly improve fertility parameters in women with ovarian aging. The systematic review and meta-analysis of therapeutic management in women with diminished ovarian reserve (DOR) reports that oral nutritional supplements such as vitamins, coenzyme Q10, and DHEA can reduce FSH, increase AMH and antral follicle count, increase oocyte and high‑quality embryo numbers, and improve clinical pregnancy rates in DOR women undergoing IVF/ICSI, although the recommendation is weak and framed as complementary therapy rather than primary treatment. [25] For thyroid-related fertility, a systematic review and meta-analysis of randomized controlled trials on levothyroxine treatment in women with subclinical hypothyroidism (SCH) examined fertility and pregnancy outcomes, indicating that thyroid hormone replacement can be clinically relevant in a subset of women with thyroid-related fertility issues, although effects on live birth and pregnancy outcomes are nuanced. [23] Regarding structural uterine factors, a systematic review and meta-analysis of fibroids and natural fertility supports that fibroids may interfere with natural fertility, and other evidence indicates that fertility-sparing surgical management (e. [24] g. , myomectomy for submucosal fibroids) can improve pregnancy rates in infertile women, thereby indirectly supporting the claim that appropriate medical/surgical management can aid fertility and subsequent pregnancy. Overall, these high-quality studies support the concept that evidence-based, condition-specific interventions (antioxidants in ovarian aging/DOR, levothyroxine in selected thyroid conditions, surgery for fibroids) can enhance fertility and support pregnancy in defined clinical populations, but they do not support broad, universal claims that generic supplements alone reliably “support fertility and pregnancy” for all women. [27][29]
- Contradicts
- Evidence also indicates important limitations and contradictions that weaken broad claims of fertility and pregnancy support, especially for generalized supplement use. [27] The systematic review and meta-analysis of antioxidants in women with ovarian aging shows improvements in intermediate fertility markers and clinical pregnancy rates, but it does not demonstrate strong or consistent effects on live birth rates, and benefits are most evident with coenzyme Q10 at specific doses and timing rather than with all antioxidants or supplement regimens. [22][24][25][26][28][29] The DOR management meta-analysis likewise concludes that oral nutritional supplements may help and have “certain clinical value” but only supports a weak recommendation, emphasizing that these are complementary therapies and that evidence quality and consistency are limited. The systematic review and meta-analysis of levothyroxine treatment in subclinical hypothyroidism examines fertility and pregnancy outcomes and highlights that levothyroxine does not uniformly improve live birth, miscarriage, or overall pregnancy outcomes across all women with SCH, contradicting any blanket claim that thyroid hormone therapy broadly enhances fertility or pregnancy in mild thyroid dysfunction. [23] The fibroids and natural fertility meta-analysis specifically notes that epidemiological data suggest but do not definitively demonstrate that fibroids interfere with natural fertility, indicating that the relationship between fibroids, fertility, and pregnancy is complex and not fully resolved. This undermines overly simplistic claims that any treatment for fibroids automatically supports fertility and pregnancy without careful patient selection and evidence-based management. Taken together, these findings contradict strong, generalized influencer-style claims that supplements or single interventions reliably “support fertility and pregnancy” across the board. Benefits are conditional, modest, and dependent on the underlying diagnosis, with notable gaps in high‑quality data on live birth and long‑term pregnancy outcomes.
- Mainstream view
- The mainstream medical and scientific position is that fertility and pregnancy outcomes are best supported through comprehensive, diagnosis-driven care rather than generic supplement-based approaches. [23][24][29] Current evidence and specialist guidelines support individualized evaluation of women with infertility or adverse pregnancy outcomes, including assessment of ovarian reserve, thyroid function, uterine anatomy (e. g. , fibroids), and other systemic factors. In women with ovarian aging or diminished ovarian reserve, mainstream practice recognizes that certain antioxidant or nutritional regimens (especially coenzyme Q10 and related supplements Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim). [22][25][26][27][28]
“thyroid conditions, hormones, fertility, and pregnancy support”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Chloe Skidmore is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Specialty lab testing for immune dysregulation and food sensitivities as within their scope of practice.
Specialty lab testing for immune dysregulation and food sensitivities
- Supports
- High-quality evidence shows that immune dysregulation is a well-established medical concept describing abnormal immune responses, including inappropriate activation (autoimmunity, allergy, cytokine storm) and suppression (immunodeficiency, immune exhaustion). Narrative and systematic reviews on inborn errors of immunity describe primary immune regulatory disorders where genetic defects in pathways such as type I interferon signaling, regulatory T-cell function, and other key immune regulators lead to autoimmunity, hyperinflammation, and immunodeficiency, directly framing these conditions as immune dysregulation diseases. [31][32][33] Reviews of immune dysregulation in sepsis and severe infections (including SARS-CoV-2 and related coronaviruses) show a pattern of simultaneous hyperinflammation, cytokine storm, and immune paralysis, with altered innate and adaptive cell function, apoptosis, and disturbed Th1/Th2/Th17/Treg balance, which is explicitly described as systemic immune dysregulation. A systematic review on pesticide exposure mechanisms concludes that many pesticides have immunotoxic effects, interfere with immune tolerance and control, and can initiate or amplify detrimental immune responses, which constitutes environmentally driven immune dysregulation. [30] Another systematic review focused on pesticide exposure and cancer risk similarly notes that chronic exposure can dysregulate Th1/Th2/Th17 cytokines and lead to immune exhaustion and poor outcomes in breast cancer, again reinforcing that immune dysregulation is a recognized mechanistic pathway. Meta-analyses and systematic reviews of immune checkpoint inhibitors demonstrate that these drugs deliberately disrupt inhibitory immune pathways to enhance anti-tumor immunity but also break immune tolerance and cause immune-related adverse events such as autoimmunity and organ-specific inflammation, which major oncology guidelines describe as treatment-induced immune dysregulation. Major clinical reviews and institutional descriptions of primary immune regulatory disorders (PIRD) define immune dysregulation in mainstream terms as disturbed immune tolerance with excessive inflammation and autoimmunity due to defects in regulatory T cells and other checkpoints. Overall, these high-quality sources support the general claim that immune dysregulation is real, clinically important, and mechanistically well documented across genetic disorders, environmental exposures, cancer immunotherapy, infections, and sepsis. contradicts
“gut health, hormonal dysfunction, environmental toxins, immune dysregulation or food sensitivities”
Rule: K.S.A. §65-2871 (Kansas Healing Arts Act)
Manipulation
False Authority
transcript · cited
A chiropractor (DC) is licensed for musculoskeletal/spine care, not for diagnosing or managing systemic internal diseases like diabetes or heart disease. Using 'Dr.' and 'holistic doctor' to imply general medical competence is a classic false authority grift. Likely motive: To attract patients with serious chronic conditions who would otherwise see an MD/DO, bypassing standard insurance and medical oversight.
“I'm Dr. Chloe Skidmore, a functional holistic doctor who specializes in chronic disease, internal disorders, and women's health”
Fear Mongering
transcript · cited
Frames standard medical care as negligent ('treats symptoms but rarely addresses root cause') to create fear that the patient's condition is being missed, pushing them toward unproven 'root cause' testing. Likely motive: To justify expensive, non-standard lab panels and supplement protocols that insurance won't cover.
“Traditional medicine treats symptoms but rarely addresses the root cause. In my practice, we uncover the underlying root issues.”
Commerce & grift map
Chloe Skidmore uses a DC license to claim authority over systemic diseases (diabetes, heart disease), creating fear that 'traditional medicine' misses root causes. This drives patients to expensive, non-standard specialty labs and unproven nutraceuticals. The lack of disclosure hides the financial incentive, and the cash-only model avoids insurance scrutiny.
No FTC-style compensation disclosure
compensationDisclosures · scan
Promotion of nutraceuticals and herbals without disclosure
supplement_brand
Host self-funnel around guest content
guestCollaboration · selfFunnel
Host routes viewers to their own consult/booking links around the guest segment.
Supplements pitched
- Nutraceuticals and Herbals
“I utilize nutraceuticals, herbals, acupuncture, emotional support techniques and fascial therapies in my practice”
Labs pitched
- Specialty Lab Testing
“Specialty tests provide a deeper understanding into gut health, hormonal dysfunction, environmental toxins, immune dysregulation or food sensitivities”
How the money flows
- Supplement brand dealUndisclosed Promotion of nutraceuticals and herbals without disclosure “I utilize nutraceuticals, herbals...”
“I utilize nutraceuticals, herbals...”
- Lab testing referralUndisclosed Promotion of specialty lab panels without disclosure “I utilize a variety of laboratory tests for identifying root issues”
“I utilize a variety of laboratory tests for identifying root issues”
Sponsors and advertisers
Brands, advertisers, and agencies connected to this content, based on what it promotes and discloses.
- Nutraceuticals and Herbals (Generic)Brand
Promoted commerce partner
- Specialty Lab Testing (Generic)Brand
Promoted commerce partner
- Nutraceuticals and HerbalsBrand
Named on a surface without a compensation disclosure
- Specialty Lab TestingBrand
Named on a surface without a compensation disclosure
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: DR, Chiropractor
Verified against the federal provider registry: DC · Chiropractor · KS license 01-06113.
Chloe Skidmore holds a Chiropractor (chiropractor) license but advertises as a 'functional holistic doctor' specializing in systemic internal diseases (diabetes, heart disease), which is outside the scope of chiropractic board rules. This is credential inflation: using a narrow musculoskeletal license to imply broad medical authority.
- DC, Doctor of Chiropractic
A state-regulated professional license for spinal adjustment and musculoskeletal/nervous system care. Does not include general internal medicine, prescription pharmacology, or primary disease management.
State Chiropractic Board: Limited to evaluation/treatment of musculoskeletal and nervous-system conditions via spinal adjustment. Cannot diagnose/treat systemic diseases like diabetes or heart disease.
Permitted scope vs advertised
Kansas State Board of Healing Arts (Chiropractic) · Confidence: medium
Kansas chiropractors may examine, analyze and diagnose the human living body and its diseases using physical, thermal or manual methods and X‑ray as taught in accredited chiropractic schools, and they are expressly prohibited from prescribing or administering medicine or drugs. Their scope is framed around chiropractic methods rather than general medical management of systemic internal diseases.
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
20 of 20 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Diagnosing and managing diabetes, heart disease, hormonal imbalances, and digestive problems Rule: K.S.A. 65-2871(a) Kansas law defines chiropractic practice by physical/manual methods and X‑ray and does not affirmatively authorize chiropractors to serve as primary-care clinicians managing systemic internal diseases such as diabetes, heart disease, endocrine or digestive disorders. | Outside scope |
| Listed service Thyroid conditions Rule: K.S.A. 65-2871(a) The chiropractic statute does not affirmatively authorize diagnosis or medical management of thyroid or other endocrine diseases beyond chiropractic physical/manual assessment methods. | Outside scope |
| Listed service Autoimmunity Rule: K.S.A. 65-2871(a) Autoimmune diseases are systemic internal medical conditions and Kansas chiropractic law does not affirmatively authorize chiropractors to diagnose or manage such systemic diseases outside chiropractic methods. | Outside scope |
| Listed service Hashimoto’s Rule: K.S.A. 65-2871(a) Hashimoto’s thyroiditis is an autoimmune endocrine disease and falls outside the affirmatively described chiropractic scope, which is limited to diagnosis by physical/manual methods and X‑ray. | Outside scope |
| Listed service IBS & SIBO Rule: K.S.A. 65-2871(a) Irritable bowel syndrome and small intestinal bacterial overgrowth are gastrointestinal medical diagnoses, and Kansas statutes do not affirmatively permit chiropractors to diagnose or medically manage digestive diseases. | Outside scope |
| Listed service Anxiety & Depression Rule: K.S.A. 65-2871(a) Mental health diagnoses like anxiety and depression are not affirmatively included in Kansas’s chiropractic practice definition, which focuses on physical/manual methods and does not grant a behavioral health diagnostic scope. | Outside scope |
| Listed service Type II Diabetes Rule: K.S.A. 65-2871(a) Type II diabetes is a systemic metabolic disease, and Kansas law does not affirmatively authorize chiropractors to diagnose or manage diabetes beyond chiropractic assessment. | Outside scope |
| Listed service PCOS & Endometriosis Rule: K.S.A. 65-2871(a) Polycystic ovary syndrome and endometriosis are gynecologic/endocrine conditions, and the chiropractic scope statute does not affirmatively permit Kansas chiropractors to diagnose or medically manage such reproductive system diseases. | Outside scope |
| Listed service Chronic Fatigue Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) | Outside scope |
| Diagnosing and managing systemic internal diseases (diabetes, heart disease) outside musculoskeletal scope Rule: K.S.A. 65-2871(a) Kansas chiropractic law frames practice around chiropractic diagnostic methods and explicitly does not expand into general medical management of systemic internal diseases such as diabetes or heart disease. | Outside scope |
| Diagnosing and managing diabetes and heart disease Rule: K.S.A. 65-2871(a) Diabetes and heart disease are systemic medical conditions and Kansas statutes do not affirmatively allow chiropractors to serve as managing clinicians for these diseases. | Outside scope |
| Prescribing natural supplements to treat root causes of chronic disease Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service Fertility and pregnancy support Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service Immune dysregulation Rule: K.S.A. 65-2871(a) Diagnosing immune dysregulation as a systemic condition goes beyond the chiropractic statute’s focus on physical/manual diagnostic methods and does not appear affirmatively authorized. | Outside scope |
| Listed service More About Conditions Seen Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Prescribing supplements to treat root causes of disease Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Diagnosing immune dysregulation and food sensitivities via specialty labs Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Managing fertility and pregnancy support as medical treatment Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Specialty lab testing for immune dysregulation and food sensitivities Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Prescribing nutraceuticals for root cause treatment Rule: K.S.A. §65-2871 (Kansas Healing Arts Act) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
Sources: Kansas Statutes §65-2871 – Practice of chiropractic (description of scope), Kansas State Board of Healing Arts – Chiropractic scope summary (via FCLB), Kansas State Board of Healing Arts – Statutes and Regulations Portal, Chiropractic scope of practice: what the law allows--update 1993 (official)
Scope comparison mirror
Side-by-side view of the archived marketing homepage and what a Chiropractor scope permits near Hesston, KS. Open the mirror for the full comparison: archive on the left, permitted scope and licensed-care paths on the right.
Mirror generated 2026-07-06 19:36 UTC. The archive pane loads styles and images from the intake snapshot.
8 licensed-care paths linked for out-of-scope claims.
Disclaimer hypocrisy
Chloe Skidmore hides behind a footer disclaimer claiming 'not medical advice' while simultaneously prescribing supplements and diagnosing systemic diseases like diabetes and heart disease—a classic disclaimer hypocrisy that shields liability while practicing medicine.
When the service is also outside their license
This pattern gets sharper when the service routed to your FSA or HSA also sits outside the practitioner's licensed scope. A provider advertising to diagnose or treat conditions their state board does not authorize is already operating past the edge of their license. Pair that with a cash-pay, FSA or HSA funded model that keeps the work away from any insurer or government program, and there is no claims reviewer, no audit trail, and no payer left to ask whether the care was appropriate or even within the provider's remit. The tax advantaged dollars do the paying, the patient carries the substantiation, and the scope question never reaches anyone with the authority to raise it.
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (truehealthks.com)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission ajga_mCHXoNHNg_Oiqiih
Fight disinformation
Log a public thread where Chloe Skidmore is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Chloe Skidmore's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/ajga_mCHXoNHNg_Oiqiih. White-coat charisma isn't evidence.
Full DTMB scan on Chloe Skidmore: https://drtrustmebro.com/analyze/ajga_mCHXoNHNg_Oiqiih
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
No conversation links logged yet. Be the first above.
Nudge the Doc Bro
We could not find a public contact email for Chloe Skidmore. Reach them through their own site and ask them to review this dossier and correct anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Chloe Skidmore, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Chloe Skidmore. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: joaXp6GXCYwviKgDfhfuu
- Wall entry: /influencer/joaXp6GXCYwviKgDfhfuu
- Analysis ID: ajga_mCHXoNHNg_Oiqiih
- Source: https://truehealthks.com/
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] Guideline-Driven Management of Hypertension: An Evidence-Based Update.
- [2] ESPEN guideline: Clinical nutrition in inflammatory bowel disease.
- [3] ASPEN-FELANPE Clinical Guidelines.
- [4] When Is Parenteral Nutrition Appropriate?
- [5] Introduction: Standards of Care in Diabetes—2024 Abridged for Primary Care Professionals
- [6] Summary of Revisions: Standards of Care in Diabetes-2024.
- [7] 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2024.
- [8] Recent Updates to Clinical Practice Guidelines for Diabetes Mellitus
- [9] 2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management
- [10] 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
- [11] 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism
- [12] Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.
- [13] 2022 Update on Clinical Management of Graves Disease and Thyroid Eye Disease.
- [14] 2022 European Thyroid Association Guideline for the management of pediatric Graves’ disease
- [15] 2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children
- [16] 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma
- [17] EFNS guideline on the treatment of tension-type headache - report of an EFNS task force.
- [18] Dietary supplements and risk of cause-specific death, cardiovascular disease, and cancer: a protocol for a systematic review and network meta-analysis of primary prevention trials
- [19] Dietary Supplements—For Whom? The Current State of Knowledge about the Health Effects of Selected Supplement Use
- [20] Dietary Intake and Chronic Disease Prevention
- [21] Associations between Chronic Medical Conditions and Persistent Dietary Supplement Use: The US Military Dietary Supplement Use Study
- [22] Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis.
- [23] Effects of Levothyroxine Treatment on Fertility and Pregnancy Outcomes in Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- [24] Fibroids and natural fertility: a systematic review and meta-analysis.
- [25] Therapeutic management in women with a diminished ovarian reserve: a systematic review and meta-analysis of randomized controlled trials.
- [26] Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis
- [27] Antioxidants for female subfertility.
- [28] The Role of Antioxidant Enzymes in the Ovaries
- [29] Oxidative stress and antioxidants: exposure and impact on female fertility.
- [30] Molecular Mechanisms of Immune Regulation: A Review
- [31] Editorial: Negative Regulators of Innate Immunity and Their Role in Host Responses to Injury and Infection
- [32] Novel Discoveries in Immune Dysregulation in Inborn Errors of Immunity
- [33] Editorial: Immune dysregulation in inborn errors of immunity